Revolution Medicines (RVMD) closed an underwritten offering of 16.6 million shares at $46 apiece to certain investors for gross proceeds of $862.5 million.
The offering included prefunded warrants to purchase 2.17 million shares at $45.9999 apiece, the company said Thursday in a statement.
Revolution offered all shares and warrants in the sale.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.